Literature DB >> 29268480

What is the optimal adjuvant therapy for T3N0 lung cancer invading the chest wall?

Makoto Suzuki1, Takeshi Mori1, Kenji Shiraishi1, Koei Ikeda1, Yoshiko Masuda1, Eri Matsubara1, Chika Shirakami1, Hironori Hinokuma1.   

Abstract

Entities:  

Year:  2017        PMID： 29268480      PMCID： PMC5721065          DOI： 10.21037/jtd.2017.10.73

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  13 in total

1.  Need for a new trial to evaluate adjuvant postoperative radiotherapy in non-small-cell lung cancer patients with N2 mediastinal involvement.

Authors:  Cecile Le Péchoux; Ariane Dunant; Jean-Pierre Pignon; Dirk De Ruysscher; Françoise Mornex; Suresh Senan; Francesc Casas; Allan Price; Bernard Milleron
Journal:  J Clin Oncol       Date:  2007-03-01       Impact factor: 44.544

2.  Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base.

Authors:  Cliff G Robinson; Aalok P Patel; Jeffrey D Bradley; Todd DeWees; Saiama N Waqar; Daniel Morgensztern; Maria Q Baggstrom; Ramaswamy Govindan; Jennifer M Bell; Tracey J Guthrie; Graham A Colditz; Traves D Crabtree; Daniel Kreisel; Alexander S Krupnick; G Alexander Patterson; Bryan F Meyers; Varun Puri
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

3.  Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Authors:  Gary M Strauss; James E Herndon; Michael A Maddaus; David W Johnstone; Elizabeth A Johnson; David H Harpole; Heidi H Gillenwater; Dorothy M Watson; David J Sugarbaker; Richard L Schilsky; Everett E Vokes; Mark R Green
Journal:  J Clin Oncol       Date:  2008-09-22       Impact factor: 44.544

4.  Non-Small Cell Lung Cancer, Version 6.2015.

Authors:  David S Ettinger; Douglas E Wood; Wallace Akerley; Lyudmila A Bazhenova; Hossein Borghaei; David Ross Camidge; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Thomas J Dilling; M Chris Dobelbower; Ramaswamy Govindan; Frederic W Grannis; Leora Horn; Thierry M Jahan; Ritsuko Komaki; Lee M Krug; Rudy P Lackner; Michael Lanuti; Rogerio Lilenbaum; Jules Lin; Billy W Loo; Renato Martins; Gregory A Otterson; Jyoti D Patel; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; Steven E Schild; Theresa A Shapiro; Scott J Swanson; Kurt Tauer; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2015-05       Impact factor: 11.908

Review 5.  Postoperative Adjuvant Systemic Therapy in Completely Resected Non-Small-Cell Lung Cancer: A Systematic Review.

Authors:  Penelope Bradbury; Duvaraga Sivajohanathan; Adrien Chan; Swati Kulkarni; Yee Ung; Peter M Ellis
Journal:  Clin Lung Cancer       Date:  2016-07-12       Impact factor: 4.785

Review 6.  Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.

Authors:  Mark G Kris; Laurie E Gaspar; Jamie E Chaft; Erin B Kennedy; Christopher G Azzoli; Peter M Ellis; Steven H Lin; Harvey I Pass; Rahul Seth; Frances A Shepherd; David R Spigel; John R Strawn; Yee C Ung; Michael Weyant
Journal:  J Clin Oncol       Date:  2017-04-24       Impact factor: 44.544

7.  Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer.

Authors:  Usman Ahmad; Traves D Crabtree; Aalok P Patel; Daniel Morgensztern; Cliff G Robinson; A Sasha Krupnick; Daniel Kreisel; David R Jones; G Alexander Patterson; Bryan F Meyers; Varun Puri
Journal:  Ann Thorac Surg       Date:  2017-04-19       Impact factor: 4.330

Review 8.  Chest wall resection for lung cancer: indications and techniques.

Authors:  Erich Stoelben; Corinna Ludwig
Journal:  Eur J Cardiothorac Surg       Date:  2009-02-01       Impact factor: 4.191

Review 9.  Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysis.

Authors:  Charlotte Billiet; Herbert Decaluwé; Stephanie Peeters; Johan Vansteenkiste; Christophe Dooms; Karin Haustermans; Paul De Leyn; Dirk De Ruysscher
Journal:  Radiother Oncol       Date:  2013-10-04       Impact factor: 6.280

10.  Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

Authors:  Jean-Pierre Pignon; Hélène Tribodet; Giorgio V Scagliotti; Jean-Yves Douillard; Frances A Shepherd; Richard J Stephens; Ariane Dunant; Valter Torri; Rafael Rosell; Lesley Seymour; Stephen G Spiro; Estelle Rolland; Roldano Fossati; Delphine Aubert; Keyue Ding; David Waller; Thierry Le Chevalier
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.